Newman Dignan & Sheerar’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGEN
Newman Dignan & Sheerar's OGEN Position: Q1 2023 in Review
Newman Dignan & Sheerar sold out of Oragenics (OGEN) in Q1 2023, closing a stake of 6 shares — an estimated $1.1K sold.
Newman Dignan & Sheerar first reported a position in OGEN in Q3 2021 and held it in 5 quarters. The position peaked at $7K in Q3 2021. 10 funds tracked by Wall St. Rank hold OGEN as of Q1 2023.
- Newman Dignan & Sheerar reported no remaining Oragenics position as of Q1 2023 after selling out during the quarter.
- Newman Dignan & Sheerar sold 6 Oragenics shares in Q1 2023, an estimated $1.1K.
- Newman Dignan & Sheerar first reported a position in Oragenics in Q3 2021 and held it in 5 quarters.
- Newman Dignan & Sheerar's Oragenics position peaked at $7K in Q3 2021.
- 10 funds tracked by Wall St. Rank held Oragenics as of Q1 2023.
Based on Newman Dignan & Sheerar's 13F filing for Q1 2023, filed 28 Apr 2023.